NEL ICB Latent Tuberculosis Infection (LTBI) Screening Programme (Lots 1-6)

The Authority has concluded a competitive process under Provider Selection Regime to appoint a provider of National Latent Tuberculosis Infection (LTBI) Service - Testing Service for City and Hackney. The Latent Tuberculosis Infection (LTBI) Screening Programme aims to reduce the incidence of active tuberculosis (TB) through the early identification and treatment of individuals infected with Mycobacterium tuberculosis who do not have active disease. By preventing progression to active TB, the programme contributes to the elimination of TB as a public health threat and supports national and global TB reduction strategies. Specifically, the programme aims to: • Prevent the development of active, transmissible TB through detection and treatment of LTBI; • Protect public health by interrupting the chain of transmission within communities; • Support national TB control and elimination goals; • Promote health equity by ensuring access to screening and care for populations at increased risk. The service aims to reduce the incidence of tuberculosis (TB) across the populations of City & Hackney. This process concentrates on decreasing and eliminating TB cases from the local population by reducing the risk of future reactivation of TB.

The Authority has concluded a competitive process under Provider Selection Regime to appoint a provider of National Latent Tuberculosis Infection (LTBI) Service - Testing Service for Newham. The Latent Tuberculosis Infection (LTBI) Screening Programme aims to reduce the incidence of active tuberculosis (TB) through the early identification and treatment of individuals infected with Mycobacterium tuberculosis who do not have active disease. By preventing progression to active TB, the programme contributes to the elimination of TB as a public health threat and supports national and global TB reduction strategies. Specifically, the programme aims to: • Prevent the development of active, transmissible TB through detection and treatment of LTBI; • Protect public health by interrupting the chain of transmission within communities; • Support national TB control and elimination goals; • Promote health equity by ensuring access to screening and care for populations at increased risk. The service aims to reduce the incidence of tuberculosis (TB) across the populations of Newham. This process concentrates on decreasing and eliminating TB cases from the local population by reducing the risk of future reactivation of TB.

The Authority has concluded a competitive process under Provider Selection Regime to appoint a provider of National Latent Tuberculosis Infection (LTBI) Service - Testing Service for Tower Hamlets. The Latent Tuberculosis Infection (LTBI) Screening Programme aims to reduce the incidence of active tuberculosis (TB) through the early identification and treatment of individuals infected with Mycobacterium tuberculosis who do not have active disease. By preventing progression to active TB, the programme contributes to the elimination of TB as a public health threat and supports national and global TB reduction strategies. Specifically, the programme aims to: • Prevent the development of active, transmissible TB through detection and treatment of LTBI; • Protect public health by interrupting the chain of transmission within communities; • Support national TB control and elimination goals; • Promote health equity by ensuring access to screening and care for populations at increased risk. The service aims to reduce the incidence of tuberculosis (TB) across the populations of Tower Hamlets. This process concentrates on decreasing and eliminating TB cases from the local population by reducing the risk of future reactivation of TB.

The Authority has concluded a competitive process under Provider Selection Regime to appoint a provider of National Latent Tuberculosis Infection (LTBI) Service - Testing Service for Redbridge. The Latent Tuberculosis Infection (LTBI) Screening Programme aims to reduce the incidence of active tuberculosis (TB) through the early identification and treatment of individuals infected with Mycobacterium tuberculosis who do not have active disease. By preventing progression to active TB, the programme contributes to the elimination of TB as a public health threat and supports national and global TB reduction strategies. Specifically, the programme aims to: • Prevent the development of active, transmissible TB through detection and treatment of LTBI; • Protect public health by interrupting the chain of transmission within communities; • Support national TB control and elimination goals; • Promote health equity by ensuring access to screening and care for populations at increased risk. The service aims to reduce the incidence of tuberculosis (TB) across the populations of Redbridge.

The Authority has concluded a competitive process under Provider Selection Regime to appoint a provider of National Latent Tuberculosis Infection (LTBI) Service - Testing Service for Waltham Forest. The Latent Tuberculosis Infection (LTBI) Screening Programme aims to reduce the incidence of active tuberculosis (TB) through the early identification and treatment of individuals infected with Mycobacterium tuberculosis who do not have active disease. By preventing progression to active TB, the programme contributes to the elimination of TB as a public health threat and supports national and global TB reduction strategies. Specifically, the programme aims to: • Prevent the development of active, transmissible TB through detection and treatment of LTBI; • Protect public health by interrupting the chain of transmission within communities; • Support national TB control and elimination goals; • Promote health equity by ensuring access to screening and care for populations at increased risk. The service aims to reduce the incidence of tuberculosis (TB) across the populations of Waltham Forest. This process concentrates on decreasing and eliminating TB cases from the local population by reducing the risk of future reactivation of TB.

The Authority has concluded a competitive process under Provider Selection Regime to appoint a provider of National Latent Tuberculosis Infection (LTBI) Service - Testing Service for Barking and Dagenham. The Latent Tuberculosis Infection (LTBI) Screening Programme aims to reduce the incidence of active tuberculosis (TB) through the early identification and treatment of individuals infected with Mycobacterium tuberculosis who do not have active disease. By preventing progression to active TB, the programme contributes to the elimination of TB as a public health threat and supports national and global TB reduction strategies. Specifically, the programme aims to: • Prevent the development of active, transmissible TB through detection and treatment of LTBI; • Protect public health by interrupting the chain of transmission within communities; • Support national TB control and elimination goals; • Promote health equity by ensuring access to screening and care for populations at increased risk. The service aims to reduce the incidence of tuberculosis (TB) across the populations of Barking and Dagenham. This process concentrates on decreasing and eliminating TB cases from the local population by reducing the risk of future reactivation of TB.

NHS North East London Integrated Care Board (ICB) is seeking to Commission National Latent Tuberculosis Infection (LTBI) Service - Diagnostic Analysis North East London (NEL) ICB is committed to ensuring local residents receive high quality care and live well in the community. This service will support patients to have access to latent TB infection testing, providing definitive indication of latent TB enabling follow-up treatment in their local community. The service supports the delivery of integrated working and the strategic aim of the national TB testing and treatment programme. The service specification deals with the procurement of services related to one part of the pathway - that of the LTBI test analysis of blood samples. The service is for the provision and analysis of the Interferon Gamma Release Assay (IGRA) test for identification of LTBI. The Latent Tuberculosis Infection (LTBI) Screening Programme aims to reduce the incidence of active tuberculosis (TB) through the early identification and treatment of individuals infected with Mycobacterium tuberculosis who do not have active disease. By preventing progression to active TB, the programme contributes to the elimination of TB as a public health threat and supports national and global TB reduction strategies. Specifically, the programme aims to: • Prevent the development of active, transmissible TB through detection and treatment of LTBI; • Protect public health by interrupting the chain of transmission within communities; • Support national TB control and elimination goals; • Promote health equity by ensuring access to screening and care for populations at increased risk. The service aims to reduce the incidence of tuberculosis (TB) across the populations of Newham. This process concentrates on decreasing and eliminating TB cases from the local population by reducing the risk of future reactivation of TB.